510(k) Report

510(k) · Cleared

Recalled · Class I · 2026

Tandem Mobi Insulin Pump with interoperable technology

K241078510(k) TraditionalCleared Jul 26, 202498-day reviewClass II21 CFR 880.5730Recalls 4 (2 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tandem Diabetes Care, Inc. · QFG Alternate Controller Enabled Insulin Infusion Pump

Cleared on Jul 26, 2024 as substantially equivalent to K240309 (Tandem Diabetes Care, Inc., 2024) after a 98-day review. Its family tree reaches back 6 generations to 2019. 6 of the 8 devices in its family, counting itself, have a Class I recall. 1 later device descends from it. It has been recalled 4 times, including 2 Class I recalls.

Decided
Jul 26, 2024
Review
98 days
Class
Class II
Product code
QFG
Recalls
4 (2 Class I)
Predicates
1

Its longest line of descent runs back 6 generations to DEN180058 (2019). 1 later device descends from it, 1 citing it directly. 6 of the 8 devices in this family, counting this one, have a Class I recall.

  1. Root · 6 generations backDEN180058 t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 2019
  2. 5 generations backK201214 t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. · 2020 · Recalled (Class I)
  3. 4 generations backK203234 t:slim X2 Insulin Pump with Interoperable Technology (with t:connect…Tandem Diabetes Care, Inc. · 2022 · Recalled (Class I)
  4. 3 generations backK223213 Tandem Mobi Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. · 2023 · Recalled (Class I)
  5. 2 generations backK233044 Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 2023 · Recalled (Class I)
  6. 1 generation backK240309 Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 2024 · Recalled (Class I)
  7. This deviceK241078 Tandem Mobi Insulin Pump with interoperable technologyTandem Diabetes Care, Inc. · 2024
  8. Descendant · cites it directly · 0 of its ownK253074 Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 2025 · Recalled

Class I recalls in this family

Most influential descendants

Showing 1 of 1 · See all
  • K253074Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6DEN180058t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc.2019—
−5K201214t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc.2020Class I
−4K203234t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)Tandem Diabetes Care, Inc.2022Class I
−3K223213Tandem Mobi Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc.2023Class I
−2K233044Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc.2023Class I
−1K240309Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc.2024Class I
0 (this device)K241078Tandem Mobi Insulin Pump with interoperable technologyTandem Diabetes Care, Inc.2024—
+1K253074Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc.20251

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K241078, 2019–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

6 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QFG device

  1. #1 K251032 MiniMed 780G insulin pumpscore 19.6 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K240309Tandem Mobi insulin pump with interoperable technology
Summary page 4
…ate Controller Enabled Infusion Pump Regulation Number 21 CFR 880.5730 Device Class Class II Predicate Device K240309, Tandem Mobi Insulin Pump with interoperable technology I. Device Under Review Th…
Tandem Diabetes Care, Inc.2024Class I
†DEN170088Dexcom G6 Continuous Glucose Monitoring SystemDexcom, Inc.2018—
†K200467Control-IQ TechnologyTandem Diabetes Care, Inc.2020—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253074Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc.20250

Has anything in its family been recalled? (6 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 23, 2026Not classifiedZ-0316-2027Process change controlTandem Diabetes Care, Inc. ( Tandem ) has identified that certain Tandem Mobi insulin pumps may generate false-positive occlusion alarms when no actual insulin flow obstruction is present. Investigation determined that increased friction…
Oct 6, 2025Class IZ-0427-2026Software designInsulin pump includes a vibration motor that gives tactile feedback for any alerts, alarms, or malfunctions. Pump may exhibit false vibration motor failure due to a software issue causing Malfunction 12: "Pump cannot operate, the mobile…
Aug 5, 2025Class IIZ-0232-2026Software change controlA software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic…
Feb 27, 2025Class IZ-1520-2025Software Design ChangeA software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV)…

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K240309Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 2024 · Direct predicate · ◆ on the line of descent in FIG. 11 Class I recall
  • K233044Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 2023 · 2 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K223213Tandem Mobi Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. · 2023 · 3 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K203234t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)Tandem Diabetes Care, Inc. · 2022 · 4 generations back · ◆ on the line of descent in FIG. 11 Class I recall
  • K201214t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. · 2020 · 5 generations back · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 5 years and passes through 1 company; a new generation was cleared every 1.3 years on median.
  • 5 of the 6 ancestors have a recall of any class; 5 have a Class I recall.
  • Of its descendants, K253074 (Tandem Diabetes Care, Inc., 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All QFG devices

QFG Alternate Controller Enabled Insulin Infusion Pump: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · QFG

5in 2025

2019: 22020: 12022: 22023: 92024: 52025: 52026 (partial year): 6
2007high 9 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QFG

44in 2025

2023: 150 days median2024: 89 days median2025: 44 days median2026 (partial year): 103 days median
2007high 150 (2023) · low 44 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QFG

8so far in 2026, the most since 2007

2022: 12023: 1, 1 Class I2025: 3, 1 Class I2026 (partial year): 8, 1 Class I
2007high 8 (2026) · low 0 (2007)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · QFG

324,360in 2025

2020: 30,5222021: 74,7012022: 129,1192023: 188,0142024: 273,1802025: 324,360
2007high 324,360 (2025) · low 0 (2007)2025

MAUDE reports naming product code QFG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20192—00
20201—030,522
20210—074,701
20222—1129,119
202391501 (1)188,014
20245890273,180
20255443 (1)324,360
202661038 (1)—

What is it indicated for?

The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices.

The pump is intended for single patient, home use and requires a prescription.

The pump is indicated for use in individuals 2 years of age and greater.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K241078: Tandem Mobi Insulin Pump with interoperable technology.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K241078

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026